Suppressive effects of a herbal formula, TBL-1, on type II collagen-induced arthritis in DBA/1J mice

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 3, 1996, Pages 236-240

  Li, Song Hua ^a   Kobayashi, Yuta ^a,b   Yamauchi, Yasutaka ^a,b   Gonda, Tatsuo ^a   Tsunematsu, Tokugoro ^a,b  

^a SHIMANE UNIVERSITY   (Japan)

^b Shimane Institute of Health Science   (Japan)

Author keywords

arthritis; collagen; DBA 1J mice; immunoregulation; TBL 1

Indexed keywords

CHINESE DRUG; COLLAGEN TYPE 2; HERBACEOUS AGENT; INDOMETACIN; TBL 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0029999285     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02602.x     Document Type: Article

References (21)

1. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum. 1990; 33: 121-30.
2. Pullar T. Disease modifying drugs for rheumatoid arthritis: Yesterday's treatment today or today's treatment tomorrow? Br. J. Clin. Pharmacol. 1990; 30: 501-10.
3. Situnayake RD, Grindulis KA, McConkey B. Long term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine; a comparison using life-table methods. Ann. Rheum. Dis. 1987; 46: 177-83.
4. Weinblatt ME, Coblyn JS, Fraser PA et al. Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum. 1987; 30: 11-17.
5. Chen JF, Qiu LQ. Clinical and experimental studies of Tong-Bi-Ling on treatment of rheumatoid arthritis. J. Integrated Trad. Western Med. (China) 1994; 94 (Suppl.): 163-6.
6. Chen JF, Qui LQ. The influence of Tong-Bi-Ling on blood dynamics in rheumatoid arthritis. J. N. TCM (China) 1993; 1: 53-4.
7. Chen JF, Li SH, Qiu LQ. Tong Bi Ling for the treatment of rheumatoid disease: An observation of 52 cases. J. Guangzhou Coll. TCM (China) 1991; 8: 139-42.
8. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: An experimental model of arthritis. J. Exp. Med. 1977; 146: 857-68.
9. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980; 283: 666-8.
10. Holmdahl R, Andersson M, Tarkowski A. Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes. Immunology 1987; 61: 369-74.
11. Nabozny GH, David CS. The immunogenetic basis of collagen induced arthritis in mice: An experimental model for the rational design of immunomodulatory treatments of rheumatoid arthritis. In: Atassi MZ (ed.). Immunobiology of Proteins and Peptides VII. Plenum Press, New York. 1994; 55-63.
12. Nishikaku F, Koga Y. Suppression of murine collagen-induced arthritis by treatment with a novel thiazole derivative, SM-8849. Immunopharmacology 1993; 25: 65-74.
13. Edmonds JP, Scott DL, Furst DE, Brooks P, Paulus HE. Antirheumatic drugs: A proposed new classification. Arthritis Rheum. 1993; 36: 336-9.
14. Björk J, Kleinau S. Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice. Agents Actions 1989; 27: 319-21.
15. Gilman SC, Carlson RP, Daniels JF et al. Immunological abnormalities in rats with adjuvant-induced arthritis. II. Effect of antiarthritic therapy on immune function in relation to disease development. Int. J. Immunopharmacol. 1987; 9: 9-16.
16. Stuart JM, Townes AS, Kang AH. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 1982; 69: 673-83.
17. Nakamura M, Ogawa H, Tsunematsu T. Isolation and characterization of a monoclonal nonspecific suppressor factor (MNSF) produced by a T cell hybridoma. J. Immunol. 1986; 136: 2904-9.
18. Trentham DE, Dynesius RA, David JR. Passive transfer by cells of type II collagen-induced arthritis in rats. J. Clin. Invest. 1978; 62: 359-66.
19. Andriopoulos NA, Mestecky J, Miller EJ, Bradley EL. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 1976; 19: 613-17.
20. Clague RB, Shaw MJ, Holt PJL. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann. Rheum. Dis. 1980; 39: 201-6.
21. av1 haplotype. Arthritis Rheum. 1993; 36: 254-8.